Curaleaf Holdings, Inc. is a medical and recreational marijuana dispensary operator in the United States. The company owns and operates dispensaries and cultivation sites, serving registered patients across multiple states including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. Curaleaf International operates across Europe, Australasia, and North America. The company focuses on highly populated states and provides products through its retail network.

Summarised from the company's own disclosures, fiscal year ended Oct 2026

Industry Specialty Retail Homepage ir.curaleaf.com
Sector Consumer Cyclical IR page ir.curaleaf.com
Tags
medical marijuana, recreational cannabis, dispensary operations, cannabis cultivation, patient services, Curaleaf International
Press page ir.curaleaf.com/press-releases

Metrics

Valuation  
Market cap C$ 2.75B
Market cap (USD) $ 1.922B
P/E -60.05
PEG —
P/BV —
P/S 1.52
P/OCF 13.96
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE -28.2%
ROI -30.2%
ROIC -30.2%
Profit margin -18.0%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock —
Diluting (TTM) —
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -66.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2020 FY 2019
Revenue 626.637M 221.018M
Net profit -61.735M -67.244M
Free cash flow -113.918M -120.396M

Filed figures

Figure Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — 60.4M 52.2M 55.7M 64M 73.9M
↳ YoY growth -13.7% +6.7% +15.0% +15.4%
Borrowings, current (USD) — 1.97M 52M 39.5M 102M 35.7M
Borrowings, non-current (USD) — 458M 571M 548M 467M 513M
Lease liabilities (USD) — 193M 309M 296M 285M 278M
Cash and deposits (USD) 73.5M 299M 163M 91.8M 107M 102M
Intangible assets (USD) — 1.04B 1.22B 1.17B 1.09B 1.01B
Right-of-use assets (USD) — 76M 123M 118M 117M 113M
Net debt (borrowings + leases - cash) (USD) — 353M 769M 792M 747M 725M
Cash flow detail
Operating cash flow (USD) — -58.3M 46.4M 75.3M 163M 138M
Purchases of property, plant and equipment (USD) — -172M -138M -65.4M -93.2M -63.4M
Purchases of intangible assets (USD) — — 0.00 -4.86M -5M -1.21M
Change in receivables (cash effect) (USD) — -25.3M 7.96M -12.2M -7.91M -11M
Change in inventories (cash effect) (USD) — -93.1M 31.2M 9.85M 2.99M -3.72M
Change in payables (cash effect) (USD) — -10.3M 51.7M 2.23M -5.63M -5.2M
Interest paid (cash effect) (USD) — -33.4M -78.8M -97.9M -96.4M -104M
Income taxes paid (cash effect) (USD) — -91.8M -156M -100M -16.5M -27.1B
Share-based compensation (USD) — 39.5M 28M 20M 25.7M 35.7M
Operating cash flow before change in receivables (USD) — -33M 38.4M 87.5M 170M 149M
Free cash flow (OCF - PPE - intangibles) (USD) — -230M -92M 4.96M 64.4M 73.1M
Income detail
Research and development expense (USD) — — — — 1.42M 805,000
Total comprehensive income (USD) — -225M -394M -279M -235M -201M
Comprehensive income to owners (USD) — -213M -382M -274M -224M -213M
Provision for credit losses (USD) — -4.58M -12M 7.54M 276,000 977,000
Credit cost ratio (credit losses / average receivables) (%) — — 21.3% 14.0% 0.5% 1.4%
Reported May 2, 2023 May 2, 2023 Mar 7, 2024 Mar 7, 2024 Feb 27, 2026 Feb 27, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Curaleaf Holdings, Inc. — Other Events Bull 2 Bear 0 M&A

On November 10, 2026, Curaleaf Holdings, Inc. ("Curaleaf") issued a statement confirming the company has received all required competition law clearances for proposed acquisition of Aurora Cannabis.

Curaleaf Holdings, Inc. — Other Events Bull 3 Bear 0 M&A

On November 3, 2026, Curaleaf Holdings, Inc. ("Curaleaf") issued a statement regarding the alternative proposal for Aurora Cannabis. A copy of the press release is attached as Exhibit 99.1.

Third quarter 2026 net revenue of $353 million

Third quarter 2026 International revenue of $59 million

Third quarter 2026 adjusted gross profit margin of 49%

Third quarter adjusted EBITDA of $78 million

Stamford, Conn., November 03, 2026 – Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer and medical cannabis products, today reported its financial and operating results for the third quarter ended September 30, 2026. All financial information is reported in accordance with U.S. generally accepted accounting principles (“U.S. GAAP” or “GAAP”) and is provided in U.S. dollars unless otherwise indicated.

Chairman and CEO Boris Jordan said, “We are building the global leader in cannabis, and our third-quarter results provide further evidence that our strategy is delivering. Solid execution across the business is driving growth, strengthening our competitive position, and advancing our Built for Growth plan. Against a backdrop of increasing pressure on the consumer, cannabis demand remained resilient and our business delivered strong, broad-based growth.

Prompts

Curaleaf Holdings, Inc. (ticker CURA), listed in Canada.

ETFs Holding Curaleaf Holdings, Inc.

ETF Weight in ETF Shares Market value As of
WEED 21.74% 176,108 $ 1.406M Nov 17, 2026
CNBS 15.77% 1,228,128 $ 13.258M Jun 30, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
CURA canonical Common share — CA tsx 11.49 CAD 2026-11-18
CURLF Common share — US otc 10.26 USD 2026-09-30